Kolexia
Leblanc Thierry Pédiatrie
Leblanc Thierry
Pédiatrie
Hôpital Robert-Debré
Paris, France
287 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Anémie Leucémies Lymphomes Maladie de Hodgkin Anémie de Blackfan-Diamond Anémie de Fanconi Leucémie-lymphome lymphoblastique à précurseurs B et T Thrombopénie Aplasies médullaires

Collaborateurs

Voir plus
Leverger Guy
Leverger Guy
Hôpital Armand Trousseau, Paris, France
Bertrand Yves
Bertrand Yves
Institut d'hématologie et d’oncologie pédiatrique de Lyon, Lyon, France
Aladjidi Nathalie
Aladjidi Nathalie
Hôpital Pellegrin, Bordeaux, France
Baruchel Andre
Baruchel Andre
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Novartis
5 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
4 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2023
KEPHREN PUBLISHING
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
British journal of haematology   03 mars 2024
RELATIVITY-069: A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adult Participants With Recurrent or Refractory Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Essai Clinique (BMS)   26 février 2024
Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies?
Blood cells, molecules & diseases   17 février 2024
Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
Pediatric radiology   31 janvier 2024
Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
Blood   16 janvier 2024
[Congrès ASH 2023] Interview Thierry Leblanc 🎙
Youtube @ Filière de Santé Maladies Rares MaRIH   10 janvier 2024
CheckMate 744: Risk-based, Response-adapted, Phase II Open-label Trial of Nivolumab + Brentuximab Vedotin (N + Bv) for Children, Adolescents, and Young Adults With Relapsed/Refractory (R/R) CD30 + Classic Hodgkin Lymphoma (cHL) After Failure of First-line Therapy, Followed by Brentuximab + Bendamustine (Bv + B) for Participants With a Suboptimal Response (CheckMate 744: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation)
Essai Clinique (BMS)   30 novembre 2023
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Hepatology (Baltimore, Md.)   06 novembre 2023
Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program
65th ASH Annual Meeting Abstracts   02 novembre 2023
Changes in the Immunogenetic Landscape with the Age of Disease Onset in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria: An Analysis of a Cohort of Adult and Pediatric Patients from the French National Reference Center for Aplastic Anemia
65th ASH Annual Meeting Abstracts   02 novembre 2023